Professor of Surgery, University Pittsburgh
General Surgery
Dr. Sally E. Carty, MD
|
|
Give Review
Dr. Sally E. Carty practices General Surgery. She researched medicine at Penn State College of Medicine. She has 5 awards "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Pittsburgh Magazine" and "Fellow (FACS)". Doctor Sally E. Carty, MD is a published doctor. She has 99 publications published. The most current publication "The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1." She accepts all Medicare patients.
Publications
- Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules.
- Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of...
- Systematic screening after Chernobyl: insights on radiation-induced thyroid Cancer.
- Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
- Highly accurate diagnosis of Cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing...
- PAX8/PPARγ Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma.
- Techniques of Parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught.
- Molecular Testing of Thyroid Nodules: Distinguishing Misuse from Appropriate Use.
- The Small Abnormal Parathyroid Gland is Increasingly Common and Heralds Operative Complexity.
- The Final Intraoperative Parathyroid Hormone Level: How Low Should It Go?
- A multi-institutional international study of risk factors for hematoma after Thyroidectomy.
- Thyroid Nodules (≥4 cm): Can Ultrasound and Cytology Reliably Exclude Cancer?
- Intraoperative Parathyroid Hormone Criteria: The Quest for PerfectionComment on "Factors That Influence Parathyroid Hormone Half-life".
- "Colloid-Rich" follicular neoplasm/suspicious for follicular neoplasm Thyroid fine-needle aspiration specimens: Cytologic, histologic, and molecular basis for consider...
- Outcome and Prognostic Factors After Adrenalectomy for Patients with Distant Adrenal Metastasis.
- RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers.
- BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid Cancer.
- BRAF mutation detection in indeterminate Thyroid cytology specimens: Underlying cytologic, molecular, and pathologic characteristics of papillary Thyroid carcinoma.
- Suspicious ultrasound characteristics predict BRAF V600E-positive papillary Thyroid carcinoma.
- Cost impact of molecular testing for indeterminate Thyroid nodule fine-needle aspiration biopsies.
- Thyroid Paragangliomas Are Locally Aggressive.
- American Thyroid Association Statement on the Essential Elements of Interdisciplinary Communication of Perioperative Information for Patients Undergoing Thyroid Canc...
- American Thyroid Association (ATA) - Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph Node Dissection for Papillary Th...
- Good question.
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples.
- A combined molecular-pathologic score improves risk stratification of Thyroid papillary microcarcinoma.
- MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma.
- Long-term outcomes, branch-specific expressivity, and Disease-related mortality in von Hippel-Lindau type 2A.
- Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid Cancer.
- Thyroid Carcinoma: The Surgeon's Perspective.
- Failure is not a fate worse than death: Comment on "Special report: Suicidal ideation among American surgeons".
- Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.
- Medication discontinuation after curative surgery for sporadic primary Hyperparathyroidism.
- Summary statement: utility of molecular marker testing in thyroid Cancer.
- Recurrent Hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
- Thyroid surgery and surgeons: the common interest.
- The adrenal mass: correlation of histopathology with imaging.
- Contribution of molecular testing to Thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significanc...
- Differentiated thyroid Cancers of follicular cell origin.
- The utility of BRAF testing in the management of papillary thyroid Cancer.
- Optimizing surgical treatment of papillary Thyroid carcinoma associated with BRAF mutation.
- Radioiodine-resistant differentiated thyroid Cancer: hope for the future.
- Sestamibi SPECT intensity scoring system in sporadic primary Hyperparathyroidism.
- Localization of Parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive Parathyroidecto...
- Recent developments in predicting Thyroid malignancy.
- Cystic Parathyroid lesions: functional and nonfunctional Parathyroid cysts.
- Reverse referral: from pathology to endocrinology.
- Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlations.
- Radiology quiz case. Nodular fasciitis (NF).
- Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary Hyperparathyroidism.
- Loss of heterozygosity of selected tumor suppressor genes in Parathyroid carcinoma.
- Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary Hyperparathyroidism?
- A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid Cancer.
- Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid Cancer.
- The incidence of Cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
- Recurrent Hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings.
- Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature.
- 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid Cancer.
- Fractional allelic loss of Tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid Tumors.
- Repeat Thyroid nodule fine-needle aspiration in patients with initial benign cytologic results.
- Branchial cleftlike cysts of the Thyroid.
- Hyperthyroidism after Parathyroid exploration.
- Allelic loss in Parathyroid neoplasia can help characterize malignancy.
- Prevention and management of complications in Parathyroid surgery.
- Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid Tumors.
- Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic Hyperparathyroidism.
- Maternity policy and practice during surgery residency: how we do it.
- Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival.
- Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance.
- Consensus statement on the terminology and classification of central neck dissection for thyroid Cancer.
- Promising molecular techniques for discriminating among follicular Thyroid neoplasms.
- Prospective study of aggressive resection of metastatic pancreatic endocrine Tumors.
- Management of patients with persistent or recurrent primary Hyperparathyroidism.
- Decreased IL-6 secretion by fibroblasts following repeated doses of TNF alpha or IL-1 alpha: post-transcriptional gene regulation.
- Coupling of H+ gradients to catecholamine transport in chromaffin granules.
- Amine transport into chromaffin ghosts. Kinetic measurements of net uptake of biologically and pharmacologically relevant amines using an on-line amperometric technique.
- H+-ATPase and catecholamine transport in chromaffin granules.
- The isolation of intact adrenal chromaffin granules using isotonic Percoll density gradients.
- Serotonin transport in isolated platelet granules. Coupling to the electrochemical proton gradient.
- Catecholamine transport and energy-linked function of chromafffin granules isolated from a human pheochromocytoma.
- The internal pH of mast cell granules.
- Mechanisms of accumulation of tyramine, metaraminol, and isoproterenol in isolated chromaffin granules and ghosts.
- Net uptake of catecholamines into isolated chromaffin granules demonstrated by a novel polarographic technique.
- Electrochemical proton gradient in dense granules isolated from anterior pituitary.
- Interleukin-1 receptor antagonist is not detrimental to human islet cell insulin secretion but decreases insulin content.
- Primary nonfunction of human pancreatic islet xenografts is murine strain dependent.
- Success of unilateral neck exploration for sporadic primary Hyperparathyroidism.
- Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT.
- Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary Hyperparathyroidism.
- Familial pheochromocytoma due to mutant von Hippel-Lindau Disease gene.
- Retroperitoneal bronchogenic cyst masquerading clinically and radiologically as a phaeochromocytoma.
- Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I.
- Concise Parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay.
- Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.
- Prognostic markers in pheochromocytoma.
- The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1.
- Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from Thyroid neoplasms.
- Parathyromatosis: a cause for recurrent Hyperparathyroidism.
Schools
Pennsylvania State University College Of Medicine
Pa St University Hershey Med Center
National Canc Institute
Procedures Preformed
- Lymph Node Biopsy or Excision
- Open Thymectomy
- ParaThyroidectomy
- Thyroid Lobectomy
- View All
Conditions Treated
- Breast Lump
- Diaphragmatic and-or Hiatal Hernia
- HyperparaThyroidism
- Lung Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Pittsburgh Magazine
- Fellow (FACS)
Education
-
Penn State University -
Penn State College of Medicine
Hospital
-
UPMC Presbyterian Shadyside -
UPMC Passavant
Drug Facts
| NPI NUMBER | 1477525327 | |
| NPPES Provider LastName | CARTY | |
| NPPES Provider FirstName | SALLY | |
| NPPES Provider ZIPCode | 152610001 | |
| NPPES Provider State | PA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 49.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477525327 |
| Last Name Of The Provider | CARTY |
| First Name Of The Provider | SALLY |
| View All |
Similar Doctors
|
|
Dr. Eugene C. Ney, MD |
|
|
Dr. Howard D. Edington, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa E. Hogg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert J. Zeh III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman Wolmark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phoebe Abraham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Surmeet S. Chhina, MD |
|
|
Dr. John R. Klune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Lotze, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yaniv Shilo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kent R. Zettel II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masahiro Yoshida, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald L. Wickerham, MD
This Doctor is OpenDoctor Recommended.
|